Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Fibroblast growth factor receptor 4 is a protein encoded by the FGFR4 gene. It is required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. The Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development market research report provides an in-depth analysis of Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics. The report provides comprehensive information on the Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type.
The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted therapeutics development with respective active and dormant or discontinued projects.
Mechanisms of Action of Fibroblast Growth Factor Receptor 4 Pipeline Market
The mechanisms of action of the Fibroblast Growth Factor Receptor 4 pipeline market are Fibroblast Growth Factor Receptor 4 Inhibitor, Fibroblast Growth Factor Receptor 4 Antagonist, and Fibroblast Growth Factor Receptor 4 Agonist.
Fibroblast Growth Factor Receptor 4 pipeline market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
Routes of Administration in Fibroblast Growth Factor Receptor 4 Pipeline Market
The routes of administration in the Fibroblast Growth Factor Receptor 4 pipeline market are oral, intravesical, subcutaneous, and intrathecal.
Fibroblast Growth Factor Receptor 4 pipeline market, by routes of administration
For more routes of administration insights, download a free report sample
Molecule Types in Fibroblast Growth Factor Receptor 4 Pipeline Market
The molecule types in the Fibroblast Growth Factor Receptor 4 pipeline market are small molecule, recombinant protein, and fusion protein.
Fibroblast Growth Factor Receptor 4 pipeline market, by molecule types
For more molecule type insights, download a free report sample
Key Fibroblast Growth Factor Receptor 4 Pipeline Market Companies
Some of the key companies in the Fibroblast Growth Factor Receptor 4 pipeline market are Abbisko Therapeutics Co Ltd, Applied Pharmaceutical Science Inc, Astellas Pharma Inc, Bayer AG, Betta Pharmaceuticals Co Ltd, BioArdis, LLC, Blueprint Medicines Corp, BridgeBio Pharma Inc, BridGene Biosciences Inc, and Bristol-Myers Squibb Co.
Fibroblast Growth Factor Receptor 4 pipeline market, by companies
To know more about key companies, download a free report sample
Market report overview
Mechanisms of Action | Fibroblast Growth Factor Receptor 4 Inhibitor, Fibroblast Growth Factor Receptor 4 Antagonist, and Fibroblast Growth Factor Receptor 4 Agonist |
Routes of Administration | Oral, Intravesical, Subcutaneous, and Intrathecal |
Molecule Types | Small Molecule, Recombinant Protein, and Fusion Protein |
Key Companies | Abbisko Therapeutics Co Ltd, Applied Pharmaceutical Science Inc, Astellas Pharma Inc, Bayer AG, Betta Pharmaceuticals Co Ltd, BioArdis, LLC, Blueprint Medicines Corp, BridgeBio Pharma Inc, BridGene Biosciences Inc, and Bristol-Myers Squibb Co |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1).
- Reviews of Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) therapeutics and enlists all their major and minor projects.
- Assessment of Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1).
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1).
- Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Applied Pharmaceutical Science Inc
Astellas Pharma Inc
Bayer AG
Betta Pharmaceuticals Co Ltd
BioArdis LLC
Blueprint Medicines Corp
BridgeBio Pharma Inc
BridGene Biosciences Inc
Bristol-Myers Squibb Co
Eddingpharm Inc
Eisai Co Ltd
Eli Lilly and Co
EUSOL Biotech Co Ltd
Everest Medicines Ltd
Genosco Inc
H3 Biomedicine Inc
Heilongjiang ZBD Pharmaceutical Co Ltd
ImmunoForge Co Ltd
InnoCare Pharma Ltd
Jacobio Pharmaceuticals Group Co Ltd
Johnson & Johnson
Merck & Co Inc
NGM Biopharmaceuticals Inc
Shouyao Holding Co Ltd
Tyra Biosciences Inc
Vichem Chemie Research Ltd
Zhejiang Hisun Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the mechanisms of action of the Fibroblast Growth Factor Receptor 4 pipeline market?
The mechanisms of action of the Fibroblast Growth Factor Receptor 4 pipeline market are Fibroblast Growth Factor Receptor 4 Inhibitor, Fibroblast Growth Factor Receptor 4 Antagonist, and Fibroblast Growth Factor Receptor 4 Agonist.
-
What are the routes of administration in the Fibroblast Growth Factor Receptor 4 pipeline market?
The routes of administration in the Fibroblast Growth Factor Receptor 4 pipeline market are oral, intravesical, subcutaneous, and intrathecal.
-
What are the molecule types in the Fibroblast Growth Factor Receptor 4 pipeline market?
The molecule types in the Fibroblast Growth Factor Receptor 4 pipeline market are small molecule, recombinant protein, and fusion protein.
-
Which are the key companies in the Fibroblast Growth Factor Receptor 4 pipeline market?
Some of the key companies in the Fibroblast Growth Factor Receptor 4 pipeline market are Abbisko Therapeutics Co Ltd, Applied Pharmaceutical Science Inc, Astellas Pharma Inc, Bayer AG, Betta Pharmaceuticals Co Ltd, BioArdis, LLC, Blueprint Medicines Corp, BridgeBio Pharma Inc, BridGene Biosciences Inc, and Bristol-Myers Squibb Co.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.